跳至主要内容
临床试验/NCT05113602
NCT05113602已完成不适用

Validation of the EEG Signal Quality Measured by the URGOnight Device and Comparison With a Clinical Device

Urgotech2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2021年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
2
主要终点
effectiveness of the URGOnight device in detecting brain signals triggered by eye closure in the Alpha band (8-12 Hz) in comparison with the Enobio 20 device.

研究概览

简要总结

The electroencephalogram or EEG is a painless and non-invasive exploratory examination routinely performed in clinical and experimental medicine and has various applications. It is therefore relevant to develop application-specific EEG measurement devices.

The clinical development of therapies based on brain control has led to the emergence of numerous EEG devices that aim to allow mobile, autonomous, and easy use for users.

Data from the literature have proven the ability of neurofeedback (a form of biofeedback in which subjects respond to a display of their own brainwaves in order to improve their health or performance) to improve brain function in healthy or pathological subjects.

These therapeutic applications are offered in hospital settings with conventional systems and in the presence of a therapist.

The EEG measurement device URGOnight was developed with the aim of offering autonomous neurofeedback exercises at home. URGOnight is a portable device. It uses passive electrodes (which do not send an electric current) and so-called dry electrodes, i.e. no gel or conductive paste is required.

Therefore, the SIGMA study aims to evaluate the quality of the EEG signal collected by URGOnight and compare it with an electroencephalography device commonly used in clinical and research settings.

We will also evaluate the quality of the brain wave measurement usually retained in comparative studies of EEG systems.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Over 18 years old
  • Head circumference between 52 and 62 centimeters
  • Affiliated or beneficiary of a social security system
  • Protected persons in the sense of article L.1121-9 of the Public Health Code.

排除标准

  • According to declarative :
  • Use of medication or drugs with a possible effect on cognitive performance, such as benzodiazepines, antidepressants and antipsychotics
  • The experimenter cannot get a good signal between the scalp and the electrodes at the beginning of the experiment (for example because of the type of hair or for any other technical reason).

结局指标

主要结局

effectiveness of the URGOnight device in detecting brain signals triggered by eye closure in the Alpha band (8-12 Hz) in comparison with the Enobio 20 device.

时间窗: 5 min recording

次要结局

  • To compare the measurement performed by URGOnight to the measurement performed by the Enobio 20 device of Visual evoked potentials SSVEP at 4, 8, 10, 13, 15 and 20 hertz(5 min recording)
  • To compare the measurement performed by URGOnight to the measurement performed by the Enobio 20 device of SMR rhythm(10 min recording)
  • To compare the measurement performed by URGOnight to the measurement performed by the Enobio 20 device of Individual Alpha frequencies(10 min recording)

研究者

发起方
Urgotech
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Validation of the EEG Signal Quality Measured by the... | 临床试验